Information Provided By: 
Fly News Breaks for April 3, 2017
FMI
Apr 3, 2017 | 09:00 EDT
After revisiting her thesis with the stock up 82% year-to-date, William Blair analyst Amanda Murphy continues to see potential for upside in Foundation Medicine shares. The analyst is unable to pinpoint a specific catalyst for the move higher, but notes short covering likely played a role while reimbursement fundamentals appear to have shifted in the company's favor over the past few weeks. The analyst sees potential for 20%-30% in compound annual revenue growth over the next five years for Foundation and keeps an Outperform rating on the name.
News For FMI From the Last 2 Days
There are no results for your query FMI
